Products found to contain undeclared medicines
|
| |
| The United States: Recall: Ultra ZX LABS, L.L.C. issues voluntary nationwide recall of Ultra Zx since it contains undeclared sibutramine and phenolphthalein |
| |
UltraZx, Labs, L.L.C. is voluntarily recalling UltraZx weight loss supplements. This product has been found to contain undeclared sibutramine and phenolphthalein. FDA laboratory analysis of confirmed that UltraZx contains sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies have indicated that it presents a cancer causing risk. This product may also interact, in life-threating ways, with other medications a consumer may be taking. Ultra ZX LABS, L.L.C. has not received any reports of adverse events related to this recall.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm437517.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Wednesday, March 11, 2015
Issued at HKT 16:00
|
| |
